PEOPLE - Changes at mtm laboratories:
This article was originally published in Clinica
mtm laboratories, a developer of screening and diagnostic assays headquartered in Heidelberg, Germany, with a wholly-owned subsidiary in Massachusetts, US, has appointed two new heads of clinical operations. Lisa Kaufman will head up operations in the US and Petra Klement will lead operations in Europe.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.